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Thalamic relay cells receive two types of afferents: drivers,
considered responsible for relay cells' receptive field prop-
erties, and modulators, thought not to contribute signifi-
cantly to the receptive field properties, but, rather, to
modulate thalamic relay properties. Modulators often
work by slowly modifying the resting potential of the cell
and thus determining the mode of response: if sufficiently
depolarized, tonic (more linear) or if sufficiently hyperpo-
larized, burst (highly non-linear but capable of larger sig-
nal to noise ratios and cortical activation).
Thalamic drivers have two origins. Some relay cells receive
their drivers from subcortical areas, including those in the
lateral geniculate nucleus (LGN), the ventral posterior
nucleus (VP), and the ventral portion of the medial genic-
ulate body (MGBv). These have been called first order
relays (FO) since this is the first time that a particular
information type is relayed to cortex. Other relay cells
receive drivers from layer 5 of cortex, including those in
the lateral posterior nucleus (LP), the posterior medial
nucleus (POm), and the dorsal portion of the medial
geniculate body (MGBd). These are known as higher
order relays (HO). Both FO and HO relays receive mod-
ulatory inputs, mainly from brainstem areas (e.g., cholin-
ergic input from the parabrachial region, noradrenergic
input from locus coeruleus, serotoninergic input from the
dorsal raphé nucleus, etc) and from layer 6 of cortex.
We sought to determine the effects of modulators in the
two types of relays, using current and voltage clamp
recordings of rat (P12–P18) thalamic cells in the whole-
cell, patch-clamp configuration. We bath-applied general
agonists for muscarinic and serotonergic receptors and
determined their effects on relay cells of six sensory nuclei,
three FO relays (LGN, VP, and MGBv) and three HO relays
(LP, POm, and MGBd).
We have recently shown that cholinergic input (by activat-
ing muscarinic M2 receptors) hyperpolarizes about 17%
of the HO relay cells, whereas it depolarizes all FO relay
cells through M1 and possibly M3 receptors. Preliminary
results suggest that serotonergic inputs also have differen-
tial effects in FO and HO relays: 3 out of 5 cells recorded
in LP are depolarized by serotonin whereas all 4 cells from
VP and LGN are depolarized.
Furthermore, we are finding that HO and FO cells differ in
their response properties. HO cells are more likely (60%
of cells vs. 25% in FO; N = 23) to show spike frequency
adaptation, which is also stronger than in FO cells. Activa-
tion of muscarinic receptors modifies the response prop-
erties of some HO cells, largely reducing the spike
frequency adaptation.
Our results indicate that modulatory influences are differ-
ent in thalamic nuclei that process information of cortical
and non-cortical origin. They suggest that HO nuclei are
more likely to be hyperpolarized when brainstem centers
are active (waking, attention), therefore being more likely
to respond to cortical inputs in the non-linear burst mode.
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